29
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Stevens-Johnson Syndrome with Ginkgo Biloba

(Pharmacy Practice Resident) & (Assistant Clinical Professor)
Pages 65-69 | Published online: 20 Aug 2009
 

Abstract

Gingko biloba is a popular herbal remedy for improving memory. Its side effects include headaches, stomach upset, bleeding complications and dermatitis. We report another adverse reaction, a case of Stevens-Johnson syndrome (SJS), which appears to be associated with use of gingko biloba. Ingestion by our patient of two doses of a ginkgo-containing preparation resulted in exfoliative rash, blistering and other symptoms consistent with SJS. Upon aggressive treatment with corticosteroids, her rash improved, however, she still had residual symptoms five months after treatment. It is important for clinicians to be aware of this possible side effect related to use of ginkgo preparations.

Additional information

Notes on contributors

Liya Davydov

F. U. Alakbarov is Head Scientific Officer, expert in the Oriental and Folk Medicine, Institute of Manuscripts of the Azerbaijan Academy of Sciences, 8 Istiglaliyat str., Baku, 370001, Azerbaijan.

At the time of writing Liya Davydov was PharmD candidate, College of Pharmacy and Allied Health Professions, St. John’s University. Currently, she is Pharmacy Practice Resident, Mount Sinai Medical Center, New York, NY.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.